.jpg)
Procter & Gamble (P&G), a global consumer goods company with a strong presence in personal care categories, announced its financial results for the second quarter of fiscal year 2026, ended in December. During the period, the company reported net sales of USD 22.2 billion, representing a 1% increase compared to the same quarter last year.
Organic sales, which exclude the impact of foreign exchange and acquisitions and divestitures, were flat year over year. Diluted net earnings per share were USD 1.78, a 5% decrease, primarily driven by higher restructuring charges. Core earnings per share were USD 1.88, in line with the prior year.
PERSONAL CARE BUSINESS PERFORMANCE
Within personal care-related segments, P&G reported varied results. The Baby, Feminine and Family Care segment recorded a 4% organic sales decline compared to the prior year.
Baby Care organic sales declined by a low single digit, reflecting lower unit volumes and an unfavorable geographic mix, partially offset by price increases, primarily in North America.
Feminine Care organic sales also declined by a low single digit, driven by lower volumes, partially offset by innovation-driven pricing, mainly in North America, and a favorable product mix.
Family Care organic sales declined by double digits, following strong volume growth in the prior-year period.
HEALTH CARE AND PERSONAL CARE RESULTS
The Health Care segment reported 3% organic sales growth. Oral Care organic sales increased slightly, driven by a favorable premium product mix, partially offset by lower volumes and increased marketing investments.
Personal Health Care organic sales also increased slightly, supported by price increases, primarily in North America, partially offset by an unfavorable product mix.
CASH FLOW AND OUTLOOK
During the quarter, P&G generated USD 5.0 billion in operating cash flow and USD 4.3 billion in net earnings, achieving 88% adjusted free cash flow productivity. The company returned USD 4.8 billion to shareholders through USD 2.5 billion in dividends and USD 2.3 billion in share repurchases.
For fiscal year 2026, P&G maintained its outlook for total sales growth between 1% and 5%, and organic sales growth between 1% and 4%, reflecting a complex consumer and geopolitical environment.
